Trading Capital And Income Calculation

One of the questions that I get asked often at training seminars is about how much capital is required for trading and how much money one could make as a day trader. While the right answer to this is No Limit, lets try finding a more practical answer.

Knowing that the market is a place of almost infinite wealth potential, how do I set a practical figure to what I should be earning? I suggest that the best way to find that out is to look at what your qualification can get you as a salary if you were to hold down a job. Or maybe if you are not qualified enough to get a good well-paying job, then look at what some others are earning in some small business that you feel you could do as well. Lets peg that amount to 50000 per month. This is a reasonable middling amount that most beginners would make. If your averages are higher you can always rework the math. Your trading income should be equal to this.

Let us assume that we shall trade 3 times a week. That is about 12 sessions in a month. So this gives us about 4000 to be made as profits per session. The daily volatility of any stock or index is about 1 to 1.5%. Assuming a stock priced around 300-400, this would mean an average daily movement of about 4-6 points. Most of such stocks would have a trading lot size of 1000 shares. So you would need to trade one lot to capture the kind of profits that we have set out to do so. That would require you to fund the account with a margin of about 50K (minimum) to 100K.

Now let us look at the risk part of it. Normally any trading method would suggest a stoploss on such a stock at around 1%. So that would be 3-4 points of risk, making the trade a 1:1 payoff in terms of a risk to reward. This is acceptable (and cannot be less). Now if I decide not to risk more than half a percent of my capital on every trade, then my capital has to be around 1 lac (at 4000 risk per trade). Setting this kind of risk parameter will allow you to have a losing streak of 25 trades before your capital gets wiped out. While such runs are indeed possible, the probability is low.

What about the losses that shall inevitably occur? Well, that is a function of your trading method and its efficacy. It is presumed in the above calculation that you have finalised a trading method that has a positive expectancy. Higher that number the better the system. Idea here is that one should persist with the method (since it has a positive expectancy) and the method itself should produce sufficient number of trades to ensure the profit target. To illustrate, we need 12 winning trades to reach our profit goal. If the system is operating at 40% efficiency ratio, then the system will have to throw up at least 30 trades within a month. Assuming that losing streak runs shall be larger, the system will probably have to generate between 35-40 trades per month for the profit goal to be reached. This trade requirement can then be used to decide what time frame chart is to be used to produce the trades. The overall drawdown of the system as well as the number of negative runs shall also decide whether additional capital may be required.

Thus we can see that it is not just about fixing a figure to earn. It is a complete analysis of several aspects of risk, reward, trading methodology, expectancy, drawdown and runs. You can substitute different numbers for indices and margins etc. to arrive at similar numbers. This is a business. Approach it in a business-like manner.

Aspergillosis Treatment Market Opportunity Analysis, 2018-2026

Aspergillosis is a group of diseases that occur from aspergillus infection. Aspergillus is a fungus whose spores are present in the air, but does not normally cause illness. Individuals with damaged lungs, sensitive immune system, and allergies are more prone to Aspergillus induced infection. Common Aspergillus infections include invasive Aspergillosis, non-invasive Allergic Pulmonary Aspergillosis (ABPA), and Chronic Pulmonary and Aspergilloma (CPA). Invasive aspergillosis is uncommon and occurs primarily in immunocompromised people.

Click To Continue Reading on Aspergillosis Treatment Market

Chronic pulmonary aspergillosis is rare pulmonary disease, which increases symptoms of respiratory disorders such as asthma. According to a study published by European Respiratory Society (ERS) publications, in 2015, CPA is estimated to affect nearly 240,000 people in Europe. The most common form of CPA is Chronic Cavitary Pulmonary Aspergillosis (CCPA), which if left untreated can develop chronic fibrosing pulmonary aspergillosis. According to a statistics published by Centers for Disease Control and prevention, (CDC) an estimated 10% of individuals with asthma or cystic fibrosis experience an allergic reaction to aspergillus. ABPA is estimated to affect 2-15% of patients with cystic fibrosis and around 2% of all asthma patients.

Increasing prevalence of Aspergillosis and favorable government regulations are the major factors driving growth of the Aspergillosis treatment market. According to a study published in Journal of Fungi 2016, CPA is estimated to affect nearly three million people globally making it major health problem resulting in mortality and morbidity. Aspergillosis infection can be treated with antifungal and corticosteroids drugs. Corticosteroid drugs are prescribed for allergic bronchopulmonary aspergillosis treatment.

These drugs reduce inflammation and lowers respiratory symptoms such as coughing and wheezing. Some of the most frequently used drugs are methylprednisolone, prednisolone and prednisone. The U.S. Food & Drug Administration (FDA) approved various drugs for Aspergillosis infection treatment. For instance, in 2015, the U.S. FDA approved Isavuconazonium (Astellas Pharma), a prodrug form of Isavuconazole. Antifungal drugs are majorly used to treat invasive pulmonary Aspergillosis. Voriconazole, an antifungal drug is widely used due to less side effects and more effectiveness in comparison to other drugs. Itraconazole or Amphotericin B also treat the infection effectively. Caspofungin is used to treat infection, resistant to the other antifungals. Furthermore, antifungal drugs are sometimes used in combination with corticosteroids for treating ABPA. Surgeries may be required in some cases where aspergillomas are present leading to serious problems such as excessive bleeding. Antifungal drugs are generally not effective against aspergillomas, therefore surgery such as embolization is recommended. An aspergilloma is a solid mass of Aspergillus hyphae, mucus, fibrin, and other cellular debris, formed inside a pre-existing area of pulmonary cavity or scar.

5 Reasons Why Companies Should Consider Hiring Fund Administrator

Enlisting the services of a fund administrator is a smart business decision amid today’s increasingly global investment marketplace. Below are five reasons why an investment fund will benefit from having a third party fund administrator:

They act as project managers. At the early stages, fund administrators can perform such vital roles as the structuring and establishment of the prospective fund. They are the ones who can serve as the facilitator, taking on the tasks of liaising with investment managers, brokers, legal and tax counsel, auditors, supervising authorities and notary or registered agent involved in the creation of the fund.

In most cases, fund administrators also carry out the paperwork, such as drafting the memorandum of agreement, financial proposals, among others. They make sure that requested documents are completed thoroughly, and on time.

They act as the unbiased accountants. Accounting remains the core task of fund administrators. That the firm hires an external, independent administrator also would give investors the assurance that performance reports are reliable and free from unnecessary manipulation.

The fund administrator’s ability to effectively manage cloud-based technology and accurate financial database contributes a lot to investor confidence and satisfaction. In Banking 2020’s official website, it is revealed that, “…Some of the best administrators have had their internal quality management systems audited and certified under well-known international quality standards such as ISO and SAS70, providing additional comfort to investors and other parties involved with a fund served by them.”

They act as registrar and transfer agent. Record-keeping of shareholders is another important job performed by fund administrators. A good record consists of the shareholder’s name, address and number of shares owned, updated regularly and accurately. Fund administrators are also responsible for such transactions as processing and control of subscriptions, redemptions, transfer and exchange, among others. If needed, they also provide certificates for the interested parties and have power to cancel old ones. They are well-informed of the client identification procedures like Know Your Client (KYC), among others.

They act as corporate secretary. The good fund administrators can go out of their way to make sure laws and regulations are strictly complied with, and documentations are filed accordingly. They are also the ones who arrange the meetings between the managing Board and shareholders.

They ensure excellent shareholder services. Fund administrators act as the important link between the fund and potential investors, even when they act behind the scenes most of the time. For instance, calculating and relaying Net Asset Values (NAV) to shareholders is typically a task of fund administrators.